Ananda Developments Plc (ANA) RNS Announcements

Add to Alert list
Date Time Source Announcement
12 Nov 2024 07:00 AM
RNS
Director Dealing
04 Nov 2024 07:00 AM
RNS
Presenting at Aquis Showcase
31 Oct 2024 07:00 AM
RNS
Total Voting Rights
30 Oct 2024 07:30 AM
RNS
Investor Meet Company Presentation
30 Oct 2024 07:00 AM
RNS
Interims for the six months ended 31 July 2024
21 Oct 2024 07:00 AM
RNS
Ananda Developments Epilepsy Trials
09 Oct 2024 07:00 AM
RNS
Phase 1 PK Study to be conducted on MRX1
08 Oct 2024 02:45 PM
RNS
Result of General Meeting
08 Oct 2024 10:50 AM
RNS
Change of Location for General Meeting
07 Oct 2024 07:00 AM
RNS
Addition to Scientific Advisory Board
30 Sep 2024 07:00 AM
RNS
Total Voting Rights
19 Sep 2024 07:00 AM
RNS
Notice of General Meeting
16 Sep 2024 07:00 AM
RNS
Result of WRAP Retail Offer
09 Sep 2024 11:30 AM
RNS
WRAP Retail Offer for up to £100,000
09 Sep 2024 10:30 AM
RNS
Placing and Subscription to raise c.£2.15 million
29 Aug 2024 08:00 AM
RNS
Launch of CBD Whitepaper
29 Aug 2024 07:00 AM
RNS
Management accounts for quarter ended 31 July 2024
09 Aug 2024 10:56 AM
RNS
Result of AGM
05 Aug 2024 07:00 AM
RNS
Graduation to Apex segment of AQSE Growth Market
16 Jul 2024 07:00 AM
RNS
Notice of AGM
15 Jul 2024 07:00 AM
RNS
Publication of Annual Report and Accounts
11 Jul 2024 07:00 AM
RNS
Invitation to Investor Evening
26 Jun 2024 07:00 AM
RNS
Promising Results from Cardiac Fibrosis Studies
11 Jun 2024 01:27 PM
RNS
Extension of Mark Ling as Senior Statutory Auditor
31 May 2024 07:00 AM
RNS
Ananda joins cannabinoid R&D Group
30 May 2024 07:00 AM
RNS
Quarterly Trading Statement to 30 April 2024
14 May 2024 07:00 AM
RNS
Ananda Presentation to LSX Conference 2024
02 May 2024 12:00 PM
RNS
Response to FSA-FSS Cannabidiol Safety Assessment
21 Mar 2024 07:00 AM
RNS
Establishment of Scientific Advisory Board
28 Feb 2024 07:00 AM
RNS
Endometriosis Trial Drug Supply Agreement Signed
26 Feb 2024 12:00 PM
RNS
Ananda presenting at Master Investor Show
26 Feb 2024 07:00 AM
RNS
Quarterly Trading Statement to 31 January 2024
06 Feb 2024 07:00 AM
RNS
Appointment of Adviser
23 Jan 2024 07:00 AM
RNS
Appointment of Scientific Advisers
14 Dec 2023 07:00 AM
RNS
Ananda Launches New Interactive Investor Hub
29 Nov 2023 02:39 PM
RNS
Quarterly Trading Statement to 31 October 2023
14 Nov 2023 07:00 AM
RNS
Drug Supply Agreement Signed
08 Nov 2023 07:30 AM
RNS
Investor Presentation via Investor Meet Company
08 Nov 2023 07:00 AM
RNS
THC Oil Patent Application Filed
01 Nov 2023 07:00 AM
RNS
MOU signed with Nottingham Trent University
24 Oct 2023 02:20 PM
RNS
Interim Results to 31 July 2023
06 Sep 2023 07:00 AM
RNS
Issue of Convertible Loan Notes
31 Aug 2023 07:00 AM
RNS
Shareholder Update
25 Aug 2023 12:01 PM
RNS
Research Roundup
25 Aug 2023 12:01 PM
RNS
Research Roundup
24 Aug 2023 02:28 PM
RNS
Result of AGM
15 Aug 2023 07:00 AM
RNS
NHS SCOTLAND TO FUND MRX1 ENDOMETRIOSIS TRIAL
31 Jul 2023 05:44 PM
RNS
Completion of Audit & Notice of AGM
27 Jul 2023 07:00 AM
RNS
First Cannabinoid Medicines Launched
13 Jul 2023 10:22 AM
RNS
Unaudited Preliminary Results
UK 100

Latest directors dealings